Funder
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics
Reference143 articles.
1. Acharya P, Lusvarghi S, Bewley CA, Kwong PD (2015) HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth. Expert Opin Ther Targets. https://doi.org/10.1517/14728222.2015.1010513
2. Alapati D, Zacharias WJ, Hartman HA, Rossidis AC, Stratigis JD, Ahn NJ et al (2019) In utero gene editing for monogenic lung disease. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aav8375
3. Albright C (2018) Discovery of EDIT-101 for the treatment of Leber’s congenital amaurosis type 10. Editas Medicine. https://www.editasmedicine.com/wp-content/uploads/2019/10/keystone_-_albright_-_jan_2018_1518202116.pdf. Accessed 20 Feb 2021
4. Al Idrus A (2021) |JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol. FierceBiotech. https://www.fiercebiotech.com/biotech/jpm-verve-therapeutics-unveils-its-lead-program-a-one-and-done-treatment-for-genetic-high. Accessed 13 Jan 2021
5. Avery OT, MacLeod CM, McCarty M (1944) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J Exp Med. https://doi.org/10.1084/jem.79.2.137
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献